Differential interactions of desipramine with amphetamine and methamphetamine: evidence that amphetamine releases dopamine from noradrenergic neurons in the medial prefrontal cortex
- PMID: 15202777
- DOI: 10.1023/b:nere.0000026409.76261.f3
Differential interactions of desipramine with amphetamine and methamphetamine: evidence that amphetamine releases dopamine from noradrenergic neurons in the medial prefrontal cortex
Abstract
Amphetamine is more effective than methamphetamine at raising dopamine levels in the prefrontal cortex. The current study tested the hypothesis that norepinephrine transporters are involved in this difference. Using microdialysis, dopamine, norepinephrine, and serotonin were measured in the rat prefrontal cortex after administration of methamphetamine or amphetamine, with and without perfusion of desipramine. Amphetamine raised norepinephrine levels more than methamphetamine did. Desipramine raised dopamine and serotonin levels but did not alter metabolite levels. Desipramine attenuated the increase in dopamine by amphetamine while increasing the dopamine released by methamphetamine. These data suggest that methamphetamine and amphetamine differ in altering prefrontal cortical dopamine levels and in interacting with norepinephrine transporters. It is proposed that amphetamine releases dopamine in the prefrontal cortex primarily through norepinephrine transporters, whereas methamphetamine interacts minimally with norepinephrine transporters.
Similar articles
-
Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.Eur J Pharmacol. 2004 Mar 8;487(1-3):105-11. doi: 10.1016/j.ejphar.2004.01.018. Eur J Pharmacol. 2004. PMID: 15033381
-
Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat.Brain Res. 2002 May 17;936(1-2):58-67. doi: 10.1016/s0006-8993(02)02542-8. Brain Res. 2002. PMID: 11988230
-
Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex.J Neurochem. 1995 Jul;65(1):111-6. doi: 10.1046/j.1471-4159.1995.65010111.x. J Neurochem. 1995. PMID: 7790854
-
Inhibitory regulation of the prefrontal cortex following behavioral sensitization to amphetamine and/or methamphetamine psychostimulants: A review of GABAergic mechanisms.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Dec 20;95:109681. doi: 10.1016/j.pnpbp.2019.109681. Epub 2019 Jun 27. Prog Neuropsychopharmacol Biol Psychiatry. 2019. PMID: 31255648 Review.
-
Biochemical and behavioural consequences of interactions between dopaminergic and noradrenergic systems in rat prefrontal cortex.Neurochem Int. 1992 Mar;20 Suppl:225S-230S. doi: 10.1016/0197-0186(92)90243-k. Neurochem Int. 1992. PMID: 1365430 Review. No abstract available.
Cited by
-
Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets.Subst Abuse Rehabil. 2024 Aug 30;15:125-161. doi: 10.2147/SAR.S431273. eCollection 2024. Subst Abuse Rehabil. 2024. PMID: 39228432 Free PMC article. Review.
-
A new strategy for antidepressant prescription.Front Neurosci. 2010 Nov 19;4:192. doi: 10.3389/fnins.2010.00192. eCollection 2010. Front Neurosci. 2010. PMID: 21151361 Free PMC article.
-
Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man.Psychopharmacology (Berl). 2005 Nov;182(3):375-83. doi: 10.1007/s00213-005-0092-6. Epub 2005 Oct 19. Psychopharmacology (Berl). 2005. PMID: 16001106
-
Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457.J Neurosci. 2005 Mar 9;25(10):2471-7. doi: 10.1523/JNEUROSCI.2097-04.2005. J Neurosci. 2005. PMID: 15758155 Free PMC article.
-
New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development.Curr Top Behav Neurosci. 2022;57:79-126. doi: 10.1007/7854_2022_332. Curr Top Behav Neurosci. 2022. PMID: 35507283 Review.